an innovative investment platform with an exclusive focus on cellular agriculture that is advancing the development of novel technologies to provide a sustainable, environmental, and ethical solution to the global factory farming and aquaculture crises, is pleased to announce the filing of its third provisional patent application (the "Third Patent Application") on June 17, 2022, regarding the production of cultured meat that is enriched with dietary supplements or additives to help lower cholesterol levels in consumers.
The Company is also continuing to develop its own intellectual property ("IP") in the form of patents and other intangible assets in order to produce food for human consumption directly from cells.
The topic of increasing the production of food from cells is timely given that the world's supply chain is currently under duress. The global food system has been weakened by COVID-19, climate change, an energy shock and the invasion of Ukraine by Russia, to two countries of which account for 12% of the world's traded calories. António Guterres, the UN Secretary General, warned on May 18th that the coming months threaten "the spectre of a global food shortage" that could last for years.
The high cost of staple foods has already raised the number of people who cannot be sure of getting enough to eat by 440 million, to 1.6 billion.1 Therefore, CULT management has deemed it critical to develop its own IP and deploy capital to help accelerate the commercialization of cellular agriculture.